Rashin tunani mai kyau da mata ke fuskanta yayin menopause ya zama ruwan dare, kuma kamfanoni da dama suna cike da alkawarin magance shi. Wani sabon gwajin bazuwar ya gwada haɗin sinadarai guda ɗaya, kuma sakamakon ya fi sauƙi fiye da na placebo. Haɗin PQQ, GABA, caffeine da bitamin B ya doke placebo a kan wasu ma’aunin tunani, amma a wani ma’aunin hankali ya yi akasin haka.
Ga abin da binciken ya gano, da abin da ba zai iya gaya muku ba.
Takaitaccen Bayani
Gwajin an wallafa shi a BMC Nutrition (Kozma, Ratonyi, Takacs et al., 2026). An buɗe shi ga kowa: https://doi.org/10.1186/s40795-026-01535-6. An rijista shi a ClinicalTrials.gov a matsayin NCT06748989.
- Masu halarta: Mata 63 masu lafiya bayan menopause; 30 sun karɓi kari, 33 kuma placebo.
- Me aka ba su: Kayan kari mai ƙunshe da PQQ (pyrroloquinoline quinone), GABA, caffeine, bitamin da ma'adanai.
- Tsawon lokacin gwaji: Makonni 6.
- Yadda aka auna sakamako: CNS Vital Signs – tsarin gwajin kwakwalwa na kwamfuta – an yi shi a farkon da ƙarshen gwaji.
- Tsarin gwaji: An raba masu halarta 1:1, an yi masa blind biyu, an kwatanta da placebo. An yi nazari da ANCOVA tare da daidaita da ƙimar farko.
Muhimman Lambobi
Manufar farko ita ce Neurocognition Index (NCI), ƙimar gaba ɗaya. Idan aka kwatanta da placebo, rukunin da ya sha kari ya inganta da +5.89 maki (95 % CI 1.27 zuwa 10.52; p = 0.013).
Wasu fannoni na biyu ma sun nuna amfanin kari:
- Memory (ƙwaƙwalwa): +7.86 maki (p = 0.020)
- Visual Memory (ƙwaƙwalwar gani): +7.97 maki (p = 0.030)
- Cognitive Flexibility (sassaucin tunani): +7.57 maki (p = 0.039)
- Executive Functioning (aikin shugabanci): alamar ƙaruwa wadda ba ta kai mahimmanci ba (p = 0.053)
Masu binciken sun ƙara cewa kari ya haifar da kyakkyawan sakamako a fannin aikin kwakwalwa gaba ɗaya da wasu fannoni na ƙwaƙwalwa da shugabanci.
Sakamakon: Hankali Mai Ƙarfi
Takaitaccen rahoton (abstract) ya nuna sakamako mai mahimmanci ga Complex Attention (hankali mai ƙarfi) wanda ya bambanta da sauran sakamakon. A sauƙaƙe, wannan fanni bai bi ci gaban da aka samu a sauran fannoni ba. Takaitaccen ba ya ba da dalili, kuma ba ya bayar da ƙimar da zan iya ambata da ƙwarin guiwa.
Wannan yana da muhimmanci dalilai biyu. Da farko yana nuna cewa tasirin bai kasance daidaitacce a duk fannoni ba. Na biyu, yana tunatar da mu cewa idan gwaji ya gwada fannoni da yawa, wasu sakamako za su fito a wurare da ba a tsammani. Wannan na iya nuni da tasirin hakika – wani sinadari mai ƙarfafa da ke tasiri daban‑daban a kan ayyuka daban‑daban – ko kuma sakamakon bazuwar. Binciken ba zai iya tantance wanne ne ba.
Me Ya Sa Waɗannan Sinadarai?
Masu rubutun sun ce kowanne sinadari an danganta shi da hanyoyin da za su iya tallafawa lafiyar kwakwalwa. Wannan hujja ce, ba shaida ba. Gwajin ya gwada haɗin a matsayin samfur guda, don haka ba zai iya faɗi wane sinadari ya yi aiki, ko ko su ne ke aiki tare, ko kuma caffeine kaɗai ne ke da alhakin wani ɓangare na tasirin. Caffeine sananne ne a matsayin mai ƙarfafa, don haka wannan tambaya ta dace.
Ta Yaya Za a Amince da Sakamakon?
Ka ɗauki wannan a matsayin alamar farko mai fatan, ba hukunci ba.
- Karami kuma gajere. Mutane 63 a cikin makonni 6 ba su ba da wani bayani game da tasirin dogon lokaci ko lafiyar kwakwalwa a nan gaba ba. Tsayin CI na sakamakon farko ya faɗi (1.27 zuwa 10.52), don haka tasirin gaskiya na iya zama ƙanana ko babba.
- Fannonin da yawa. Binciken ya kalli fannoni da dama na tunani. Takaitaccen ba ya ambaton daidaita don gwaje‑gwajen da yawa, don haka p‑values tsakanin 0.01 da 0.04 ya kamata a karanta da kulawa.
- Samfurin haɗin. Ba za ka iya ɗaukar waɗannan sakamakon ka yi zaton kowanne sinadari guda yana aiki shi kaɗai ba.
- Mata masu lafiya kawai. Waɗannan su ne mata masu lafiya bayan menopause. Sakamakon ba ya magana ga mata da ke da matsalar tunani, damuwa, matsalar barci ko wasu cututtuka.
- Gwajin kwamfuta. CNS Vital Signs na bayar da ƙididdiga da aka daidaita, amma ƙididdiga ba su koyaushe daidaita da yadda mata ke ji a rayuwar yau da kullum ba.
- Ƙorafin marubuta. Sun ce ana bukatar manyan gwaje‑gwaje don tantance sakamakon da kuma duba tasirin dogon lokaci.
Ban samu damar duba kuɗin da aka ba da goyon baya ko rikice‑rikice daga takaitaccen ba. Ka karanta cikakken takarda mai buɗe‑hannu kafin ka yanke shawara game da mai tallafa samfurin.
Abubuwan Da Za a Yi La'akari Da Su
Matsakaici da lokuta: Takaitaccen ba ya bayar da adadin sinadaran ko jadawalin shan su, don haka ba zan iya yin hasashe ba. Abin da aka sani kawai shine gwajin ya ɗauki makonni 6. Idan kana tunanin amfani da wani samfur, duba cikakken rubutu da alamar samfur, kuma kada ka ɗauka cewa samfurin da ake sayarwa a kasuwa yana daidai da abin da aka yi amfani da shi a gwaji.
Wanene zai sha'awa: Mata masu lafiya bayan menopause da ke son tallafi na tunani kuma suke shirye su ɗauki gwaji a matsayin wani ƙoƙari. Wannan na nufin su saita wani lokaci na gwaji, su rubuta yadda suke ji, kuma su yi tsammani masu ma'ana.
Wanene ya kamata ya yi hankali ko ya guje shi (ba daga sakamakon takarda ba, amma daga lafiyar gaba ɗaya):
- Duk wanda ke da hassada ga caffeine, ko wanda ke da damuwa, bugun zuciya ko matsalar barci.
- Duk wanda ke shan magungunan da aka rubuta, musamman na damuwa, barci ko matsalar kwakwalwa. GABA da caffeine na iya yin tasiri a nan, don haka ka tambayi likita ko mai ba da magani.
- Duk wanda hankalinsa ne babban ƙalubale; ganin sakamakon “complex attention” ya nuna akasin haka.
- Duk wanda ke da “brain fog” mai tsanani, na faruwa kwatsam ko yana ƙara muni. Wannan na buƙatar duba likita, ba kari ba.
Karshe
A cikin wannan ƙaramin gwajin bazuwar na makonni 6, haɗin PQQ, GABA, caffeine da bitamin B ya ci nasara akan placebo a kan Neurocognition Index gaba ɗaya da kuma a kan ƙwaƙwalwa, ƙwaƙwalwar gani da sassaucin tunani a tsakanin mata masu lafiya bayan menopause. Sakamakon “complex attention” ya tafi akasin, yayin da aikin shugabanci ya nuna alamar ƙaruwa amma ba a tabbatar ba. Gwajin yana ba da fata, amma yana bukatar manyan, dogon lokaci don a tabbatar kafin a ɗauka a matsayin maganin fog na kwakwalwa na menopause.
Source: Kozma B, Ratonyi D, Takacs P, et al. BMC Nutrition, 2026. DOI: https://doi.org/10.1186/s40795-026-01535-6. Registration: NCT06748989. Wannan labarin yana don bayanin kawai kuma ba shawarar likita ba.